Back
Pliant Therapeutics Stock Price Chart
Sell
45
PLRX
Pliant Therapeutics
Last Price:
10.98
Seasonality Move:
50.54%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight buying pressure.
Pliant Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.31 | Sell |
| 20-day SMA: | 11.84 | Sell |
| 50-day SMA: | 12.82 | Sell |
| 200-day SMA: | 15.08 | Sell |
| 8-day EMA: | 11.23 | Sell |
| 20-day EMA: | 11.87 | Sell |
| 50-day EMA: | 12.84 | Sell |
| 200-day EMA: | 15.32 | Sell |
Pliant Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.65 | Sell |
| Relative Strength Index (14 RSI): | 36.03 | Sell |
| Chaikin Money Flow: | 25532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.06 - 13.88) | Sell |
| Bollinger Bands (100): | (12.4 - 16.14) | Sell |
Pliant Therapeutics Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 10.99 while PLRX 8-day simple moving average is 11.31, which is a Sell signal.
- The stock price of PLRX is 10.99 while Pliant Therapeutics 20-day SMA is 11.84, which makes it a Sell.
- Pliant Therapeutics 50-day simple moving average is 12.82 while PLRX share price is 10.99, making it a Sell technically.
- PLRX stock price is 10.99 and Pliant Therapeutics 200-day simple moving average is 15.08, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
45
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Sell
The current Pliant Therapeutics [PLRX] share price is $10.99. The Score for PLRX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
662.98M
Price in USD:
10.99
Share Volume:
944.7K
Pliant Therapeutics 52-Week Range
52-Week High:
21.21
52-Week Low:
10.43
Sell
45
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 10.99 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 10.99 while PLRX 8-day exponential moving average is 11.23, which is a Sell signal.
- The stock price of PLRX is 10.99 while Pliant Therapeutics 20-day EMA is 11.87, which makes it a Sell.
- Pliant Therapeutics 50-day exponential moving average is 12.84 while PLRX share price is 10.99, making it a Sell technically.
- PLRX stock price is 10.99 and Pliant Therapeutics 200-day simple moving average is 15.32, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.27 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is -0.65, suggesting Pliant Therapeutics is a Sell
- Pliant Therapeutics Relative Strength Index (RSI) is 36.03, which suggest Pliant Therapeutics is oversold
- The Bollinger Bands (25) for Pliant Therapeutics is (11.06 - 13.88), which suggest Pliant Therapeutics is a Sell
- The Bollinger Bands (100) for Pliant Therapeutics is (12.4 - 16.14), which suggest Pliant Therapeutics is a Sell
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.